Photodynamic therapy and bone marrow transplantation

This review discusses various opportunities for applications of photodynamic therapy in the field of bone marrow trans- plantation. These include the elimination of tumor cells from autologous bone marrow grafts (marrow purging), the pro- phylaxis and treatment of graft-versus-host disease, the prevention of graft rejection, and the inactivation of viruses in bone marrow grafts and blood products.

[1]  A. Rimm,et al.  Increasing utilization of bone marrow transplantation. , 1986, Transplantation.

[2]  Y. Reisner,et al.  Differential binding of soybean agglutinin to human neuroblastoma cell lines: potential application to autologous bone marrow transplantation. , 1985, Cancer research.

[3]  J. Spivak,et al.  Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation. , 1989, Bone marrow transplantation.

[4]  F. Sieber,et al.  Dye-mediated photosensitization of murine neuroblastoma cells. , 1986, Cancer research.

[5]  R. Raijmakers,et al.  Autologous bone-marrow transplantation. , 1987, Lancet.

[6]  J. Spivak,et al.  Differential sensitivity of mouse hematopoietic stem cells to merocyanine 540. , 1981, Differentiation; research in biological diversity.

[7]  A. Fefer.  Current status of syngeneic marrow transplantation and its relevance to autografting. , 1986, Clinics in haematology.

[8]  C J Gomer,et al.  DNA damage and repair in CHO cells following hematoporphyrin photoradiation. , 1980, Cancer letters.

[9]  E. Farmer,et al.  Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction. , 1985, Journal of the American Academy of Dermatology.

[10]  W. Berdel,et al.  Purging of acute myeloid leukemic cells by ether lipids and hyperthermia. , 1988, Blood.

[11]  C. Richman,et al.  Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia. , 1989, Experimental hematology.

[12]  S. Sharkis,et al.  Inactivation of Friend erythroleukemia virus and Friend virus-transformed cells by merocyanine 540-mediated photosensitization. , 1989, Blood.

[13]  G. Spitzer,et al.  Autologous bone marrow transplantation in a case of acute adult leukemia. , 1977, Transplantation proceedings.

[14]  G. Lenoir,et al.  Establishment of lymphomatous cell lines from bone marrow samples from patients with Burkitt's lymphoma. , 1984, Journal of the National Cancer Institute.

[15]  G. Santos,et al.  Bone marrow transplantation in acute leukemia. , 1982, Seminars in hematology.

[16]  C. Gomer,et al.  Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to hematoporphyrin derivative photoradiation, ionizing radiation, or ultraviolet radiation. , 1983, Cancer research.

[17]  S. Bown,et al.  PHTHALOCYANINE PHOTOSENSITIZATION FOR IN VITRO ELIMINATION OF RESIDUAL ACUTE NON‐LYMPHOBLASTIC LEUKAEMIA: PRELIMINARY EVALUATION , 1987, Photochemistry and photobiology.

[18]  K. Atkinson,et al.  PUVA therapy for drug-resistant graft-versus-host disease. , 1986, Bone marrow transplantation.

[19]  R. Storb,et al.  Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins. , 1981, Blood.

[20]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[21]  I. Brodsky,et al.  Bone marrow transplantation in acute leukemia. , 1977, Pennsylvania medicine.

[22]  L. Corash,et al.  PHOTOCHEMICAL DECONTAMINATION OF BLOOD COMPONENTS CONTAINING HEPATITIS B AND NON-A, NON-B VIRUS , 1988, The Lancet.

[23]  J. Spivak,et al.  Susceptibility to merocyanine 540-mediated photosensitization as a differentiation marker in murine hematopoietic stem cells. , 1982, Progress in clinical and biological research.

[24]  J. Spivak,et al.  Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Mackinnon,et al.  Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation. , 1988, Journal of clinical pathology.

[26]  B. Clarkson,et al.  Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow. , 1986, Cancer research.

[27]  S. Bown,et al.  Differential phthalocyanine photosensitization of acute myeloblastic leukaemia progenitor cells: a potential purging technique for autologous bone marrow transplantation , 1988, British journal of haematology.

[28]  Shirley Dex,et al.  JR 旅客販売総合システム（マルス）における運用及び管理について , 1991 .

[29]  H. Kaizer,et al.  Autologous bone marrow transplantation (ABMT) in the treatment of cancer. , 1984, Cancer investigation.

[30]  O. Colvin,et al.  Pharmacological purging of bone marrow with reference to autografting. , 1986, Clinics in haematology.

[31]  H. Deeg,et al.  Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  D. Weisenburger,et al.  Detection of malignant cells in histologically normal bone marrow using culture techniques. , 1987, Bone marrow transplantation.

[33]  F. Sieber,et al.  Mutagenicity of merocyanine 540-mediated photosensitization. , 1989, Experimental hematology.

[34]  B. Clarkson,et al.  Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts. , 1987, Blood.

[35]  M. Horowitz,et al.  Current status of bone marrow transplantation in humans: report from the International Bone Marrow Transplant Registry. , 1988, Natural immunity and cell growth regulation.

[36]  S. Jagannath,et al.  The Role of Autologous Bone Marrow Transplantation in Acute Leukemia a , 1987, Haematology and blood transfusion.

[37]  S. Jagannath,et al.  The role of autologous bone marrow transplantation in acute leukemia. , 1987, Annals of the New York Academy of Sciences.

[38]  J. Armitage,et al.  Bone marrow autotransplantation. , 1989, The American journal of medicine.

[39]  I. Magrath,et al.  Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: evidence of occult bone marrow involvement. , 1983, Blood.

[40]  H. Waldmann,et al.  T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads. , 1989, Transplantation.

[41]  N. Flournoy,et al.  Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. , 1986, The New England journal of medicine.

[42]  J. Wagner,et al.  Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial. , 1988, Blood.

[43]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[44]  L. Laroche,et al.  Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. , 1989, The Journal of investigative dermatology.

[45]  R. Stuart,et al.  Dye-mediated photolysis of normal and neoplastic hematopoietic cells. , 1987, Leukemia research.

[46]  R. Hunter,et al.  Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation. , 1987, Cancer research.

[47]  A. Porcellini,et al.  Limiting dilution analysis for detection of residual leukemic cells after bone marrow combined decontamination with mafosfamide followed by merocyanine-540-mediated photosensitization. , 1989, International journal of cell cloning.